T. Rowe Price Associates, Inc. 13D and 13G filings for MediWound Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 10:38 am Sale | 2026-06-30 | 13G | MEDIWOUND LTD MDWD | T. Rowe Price Associates, Inc. | 641,075 5.000% | -68,772 (-9.69%) | Filing |
| 2026-05-15 10:07 am Purchase | 2026-03-31 | 13G | MEDIWOUND LTD MDWD | T. Rowe Price Associates, Inc. | 709,847 5.500% | 155,349 (+28.02%) | Filing |
| 2026-02-17 10:26 am Sale | 2025-12-31 | 13G | MEDIWOUND LTD MDWD | T. Rowe Price Associates, Inc. | 554,498 4.300% | -60,005 (-9.76%) | Filing |
| 2025-11-14 12:19 pm Purchase | 2025-09-30 | 13G | MEDIWOUND LTD MDWD | T. Rowe Price Associates, Inc. | 614,503 5.500% | 614,503 (New Position) | Filing |